Home/Filings/4/0000899140-25-000486
4//SEC Filing

SUVRETTA CAPITAL MANAGEMENT, LLC 4

Accession 0000899140-25-000486

CIK 0001808898other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:37 PM ET

Size

34.4 KB

Accession

0000899140-25-000486

Insider Transaction Report

Form 4
Period: 2025-03-31
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+9,503$120,0238,802,748 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+670$8,8571,068,701 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+1,267$16,0021,068,031 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+5,057$66,8548,807,805 total(indirect: See footnotes)
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+1,267$16,0021,068,031 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+9,503$120,0238,802,748 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+5,057$66,8548,807,805 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+670$8,8571,068,701 total(indirect: See footnotes)
Averill Master Fund, Ltd.
Director10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+670$8,8571,068,701 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+1,267$16,0021,068,031 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+9,503$120,0238,802,748 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+5,057$66,8548,807,805 total(indirect: See footnotes)
Cowen Aaron
10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+5,057$66,8548,807,805 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$13.22/sh+670$8,8571,068,701 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+1,267$16,0021,068,031 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2025-03-31$12.63/sh+9,503$120,0238,802,748 total(indirect: See footnotes)
Footnotes (5)
  • [F1]Notes are included on Exhibit 99.1.
  • [F2]Notes are included on Exhibit 99.1.
  • [F3]Notes are included on Exhibit 99.1.
  • [F4]Notes are included on Exhibit 99.1.
  • [F5]Notes are included on Exhibit 99.1.

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001569064

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:37 PM ET
Size
34.4 KB